These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 35967405)
41. Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis. Grouthier V; Lebrun-Vignes B; Moey M; Johnson DB; Moslehi JJ; Salem JE; Bachelot A Oncologist; 2020 Aug; 25(8):696-701. PubMed ID: 32390168 [TBL] [Abstract][Full Text] [Related]
42. MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Nagasaka H; Kishida T; Kouro T; Igarashi Y; Takebe S; Yamamoto S; Kondo T; Koizumi M; Terao H; Suzuki T; Nakaigawa N; Himuro H; Wei F; Sasada T Int J Clin Oncol; 2024 Jun; 29(6):832-839. PubMed ID: 38580797 [TBL] [Abstract][Full Text] [Related]
43. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia. Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303 [TBL] [Abstract][Full Text] [Related]
44. Membranous nephropathy and thrombotic microangiopathy secondary to metastatic prostate cancer after Iodine-125 prostate brachytherapy: A case report . Yang L; Liang D; Cheng S; Ge Y Clin Nephrol; 2019 Sep; 92(3):155-158. PubMed ID: 31262399 [TBL] [Abstract][Full Text] [Related]
45. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1. Lin F; Zhang D; Chang J; Tang X; Guan W; Jiang G; Zhu C; Bian F Eur J Med Genet; 2018 Feb; 61(2):84-88. PubMed ID: 29079545 [TBL] [Abstract][Full Text] [Related]
47. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy. Tian C; Li L; Liu T; Qu X; Qiu Y Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982 [TBL] [Abstract][Full Text] [Related]
48. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report. Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873 [TBL] [Abstract][Full Text] [Related]
50. Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report. Kojima A; Uchida T; Sugisaki K; Koizumi M; Aoki K; Mukae M; Yamada M; Oda T Medicine (Baltimore); 2023 Oct; 102(41):e35470. PubMed ID: 37832087 [TBL] [Abstract][Full Text] [Related]
51. Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report. Hines J; Daily E; Pham AK; Shea CR; Nadeem U; Husain AN; Stadler WM; Reid P J Med Case Rep; 2021 Mar; 15(1):124. PubMed ID: 33736690 [TBL] [Abstract][Full Text] [Related]
52. Biomarkers to detect membranous nephropathy in Chinese patients. Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909 [TBL] [Abstract][Full Text] [Related]
53. A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report. Chen F; Du H; Fang S Medicine (Baltimore); 2023 Jan; 102(3):e32508. PubMed ID: 36701715 [TBL] [Abstract][Full Text] [Related]
54. Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management. Moturi K; Sharma H; Hashemi-Sadraei N Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203586 [TBL] [Abstract][Full Text] [Related]
55. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins. Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599 [TBL] [Abstract][Full Text] [Related]
56. Clinical significance of M Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127 [TBL] [Abstract][Full Text] [Related]
57. First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis. Xu J; Wang X; Weng Q; Feng X; Pan X BMC Nephrol; 2023 Sep; 24(1):283. PubMed ID: 37752421 [TBL] [Abstract][Full Text] [Related]
58. Duodenal Schwannoma as a Rare Association With Membranous Nephropathy: A Case Report. Zhang Z; Gong T; Rennke HG; Hayashi R Am J Kidney Dis; 2019 Feb; 73(2):278-280. PubMed ID: 30454884 [TBL] [Abstract][Full Text] [Related]
59. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
60. Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report. Mari R; Guerin M; Vicier C; Walz J; Bonnet N; Pignot G; Gravis G Front Immunol; 2022; 13():984132. PubMed ID: 36189265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]